ENDRA Life Sciences (NDRA) FCF Margin (2016 - 2018)

ENDRA Life Sciences (NDRA) has reported FCF Margin for 3 consecutive years, with 39713.15% the latest figure, recorded in Q1 2018.

• In Q1 2018, FCF Margin changed N/A year-over-year to 39713.15%; the TTM figure through Dec 2018 stood at 126376.43% (down 12543767.0% YoY), while the FY2018 annual figure was 126376.43%, down 12543543.0% from the prior year.
• FCF Margin slipped to 39713.15% in Q1 2018 per NDRA's latest filing, from 20081.52% in the prior quarter.
• Across five years, FCF Margin topped out at 105.93% in Q4 2016 and bottomed at 39713.15% in Q1 2018.
• Historically, FCF Margin has averaged 12413.71% across 3 years, with a median of 1977.51% in 2017.
• On a YoY basis, FCF Margin climbed as much as 1997559 bps in 2017 and fell as far as 1997559 bps in 2017.
• ENDRA Life Sciences' FCF Margin stood at 105.93% in 2016, then tumbled by 18857 bps to 20081.52% in 2017, then slumped by 98 bps to 39713.15% in 2018.
• Business Quant data shows NDRA's FCF Margin at 39713.15% in Q1 2018, 20081.52% in Q4 2017, and 190.46% in Q3 2017.